Home>Topics>>BRIEF-Lexicon Pharma up in premarket after drug candidate gets fast track status from FDA
BRIEF-Lexicon Pharma up in premarket after drug candidate gets fast track status from FDA
Reuters: Healthcare
Mon, 17 Dec 2012
NEW YORK, Dec 17 (Reuters) - Lexicon Pharmaceuticals Inc : * Lexicon Pharma up 9.1 percent to $2.04 in premarket after drug candidate for irritable bowel syndrome gets fast track status from the U.S. Food and Drug Administration